Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT00378105 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00378105
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2009-07-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.